CMES204 The Great Insulin Debate: A Critical Review of Advances in Insulin Therapy

Program: CMES Ancillary Events
Sunday, June 16, 2013: 6:30 PM-9:30 PM
Yerba Buena Salon 7 (San Francisco Marriott Marquis)

Learning Objectives:

  • Summarize the benefits and limitations of current insulin analogues
  • Describe the clinical important differences between current and emerging insulins in: glycemic efficacy, hypoglycemia, and pharmacodynamics; quality-of-life, including dosing frequency, adherence and impact  on weight; special populations including pediatrics, pregnancy, older adults, and renal insufficiency
  • Describe recent advances in insulin therapy and their implications for clinical practice
Supported by an educational grant from Novo Nordisk Inc.
7:00 PM
John (Jack) L Leahy, MD, Univ of VT Coll of Med, Colchester, VT
7:35 PM
William H Polonsky, PhD, CDE, Department of Psychiatry, Behavioral Diabetes Institute-University of California, San Diego, San Diego, CA
8:15 PM
John (Jack) L Leahy, MD, Univ of VT Coll of Med, Colchester, VT, Anthony L McCall, MD, PhD, Endocrinology, University of Virginia, Charlottesville, VA, William H Polonsky, PhD, CDE, Department of Psychiatry, Behavioral Diabetes Institute-University of California, San Diego, San Diego, CA and Guillermo E Umpierrez, MD, Internal Medicine/Endocrinology, Emory University School of Medicine
See more of: CMES Ancillary Events